128 related articles for article (PubMed ID: 16412434)
1. The AP-1/CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia.
Moore-Carrasco R; García-Martínez C; Busquets S; Ametller E; Barreiro E; López-Soriano FJ; Argilés JM
FEBS Lett; 2006 Jan; 580(2):691-6. PubMed ID: 16412434
[TBL] [Abstract][Full Text] [Related]
2. cFos is critical for MCF-7 breast cancer cell growth.
Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
4. The possible role of myostatin in skeletal muscle atrophy and cachexia.
Jespersen J; Kjaer M; Schjerling P
Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of skeletal muscle atrophy.
Ventadour S; Attaix D
Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
Carbó N; López-Soriano J; Costelli P; Busquets S; Alvarez B; Baccino FM; Quinn LS; López-Soriano FJ; Argilés JM
Br J Cancer; 2000 Aug; 83(4):526-31. PubMed ID: 10945502
[TBL] [Abstract][Full Text] [Related]
7. The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
Koopman R; Ryall JG; Church JE; Lynch GS
Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):601-6. PubMed ID: 19741516
[TBL] [Abstract][Full Text] [Related]
8. The pivotal role of cytokines in muscle wasting during cancer.
Argilés JM; Busquets S; López-Soriano FJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):2036-46. PubMed ID: 16105746
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia.
Belizário JE; Lorite MJ; Tisdale MJ
Br J Cancer; 2001 Apr; 84(8):1135-40. PubMed ID: 11308266
[TBL] [Abstract][Full Text] [Related]
10. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP
Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113
[TBL] [Abstract][Full Text] [Related]
11. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
Figueras M; Busquets S; Carbó N; Barreiro E; Almendro V; Argilés JM; López-Soriano FJ
FEBS Lett; 2004 Jul; 569(1-3):201-6. PubMed ID: 15225634
[TBL] [Abstract][Full Text] [Related]
13. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
Fuster G; Busquets S; Ametller E; Olivan M; Almendro V; de Oliveira CC; Figueras M; López-Soriano FJ; Argilés JM
Cancer Res; 2007 Jul; 67(13):6512-9. PubMed ID: 17616713
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation.
Costelli P; Muscaritoli M; Bossola M; Moore-Carrasco R; Crepaldi S; Grieco G; Autelli R; Bonelli G; Pacelli F; Lopez-Soriano FJ; Argilés JM; Doglietto GB; Baccino FM; Rossi Fanelli F
Int J Oncol; 2005 Jun; 26(6):1663-8. PubMed ID: 15870883
[TBL] [Abstract][Full Text] [Related]
15. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
16. Muscle wasting in cardiac cachexia.
Strassburg S; Springer J; Anker SD
Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
[TBL] [Abstract][Full Text] [Related]
17. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT
Mol Cancer Res; 2003 Sep; 1(11):848-54. PubMed ID: 14517347
[TBL] [Abstract][Full Text] [Related]
18. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.
Song X; Tao YG; Deng XY; Jin X; Tan YN; Tang M; Wu Q; Lee LM; Cao Y
Cell Signal; 2004 Oct; 16(10):1153-62. PubMed ID: 15240010
[TBL] [Abstract][Full Text] [Related]
19. A signaling role for dystrophin: inhibiting skeletal muscle atrophy pathways.
Glass DJ
Cancer Cell; 2005 Nov; 8(5):351-2. PubMed ID: 16286242
[TBL] [Abstract][Full Text] [Related]
20. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]